Comparison

CTCAE v4.0 vs HemeOncBuddy

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

CTCAE v4.0

This medical reference app provides a standardized system for grading the severity of adverse events related to drug treatments or medical devices. It offers hierarchical navigation, bookmarking, and search functionality for quick access to definitions and grading standards.

Highlights
  • Standardized adverse event grading system
  • Definitions for event severity (grades 1-5)
  • Hierarchical navigation of categories
  • Bookmark frequently used events
  • Search across names, definitions, and grades
Features
Read full description

The National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) is a standardized system to quantify or grade the severity of adverse events (AE) that occur with drug treatment or from medical devices. A definition of mild (grade 1), moderate (2), severe (3), life-threatening (4) and death related to AE (5) events is provided for each AE term. The CTCAE v4.02 was published by NCI on October 6, 2009, and is used by many healthcare providers and researchers to characterize adverse events consistently. The Center for Biomedical Informatics (CBMi) at The Children's Hospital of Philadelphia has converted the 190+ pages of the CTCAE v4.02 document into an intuitive iPhone application. With this application, healthcare providers can reference the full CTCAE v4.02 with an iPhone or iPod Touch, allowing for bedside grading at the time of a visit and generally allowing the information to be accessed from anywhere at any time. The application contains all published grading standards for all 26 categories of adverse events as well as event definitions. The application also offers a variety of advantages over the flat file CTCAE v4.02, including: * Hierarchical navigation of adverse event categories * Ability to bookmark adverse events and categories to quickly access frequently graded events * Search for events across names, definitions and grades This application is one example of the many ways in which CBMi helps transform clinical care and research at our institution and across the industry. The Children's Hospital of Philadelphia is a non-profit entity as defined by Section 501(c)(3) of the Internal Revenue Code of 1986. About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 460-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu. About The Center for Biomedical Informatics: The Center for Biomedical Informatics (CBMi) resides in The Children's Hospital of Philadelphia Research Institute as the home for development of innovative solutions to healthcare's immediate and long-term informatics needs. We provide informatics-focused services, products, and educational programs to Children's Hospital clinicians and researchers and seek to transform their craft with high-impact, low-cost solutions. For more information, visit http://www.research.chop.edu/cbmi. References: Please note that NCI has directed us to use the May 29, 2009 reference without regard to updates. Our app uses the most updated version of the CTCAE despite our reference to the original. National Cancer Institute Common Terminology Criteria for Adverse Events v4.0 NCI, NIH, DHHS. May 29, 2009 NIH publication # 09-7473

About

HemeOncBuddy

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

Highlights
  • Practice-changing clinical trial summaries
  • Hematology and Oncology focus
  • Simplified trial information
  • Inclusion and exclusion criteria
  • Primary endpoints and outcomes
  • Quick reference tool
Features
Read full description

HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.

Screenshots

CTCAE v4.01 screens
HemeOncBuddy4 screens

Verdict

The call

The clearest difference is review sentiment: HemeOncBuddy at 100% against CTCAE v4.0's 17%. HemeOncBuddy also leads on rating (5.0 vs 3.5). CTCAE v4.0's advantage is iOS requirement (9.2 vs 15.0). On price, ratings volume, update cadence and ads there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

HemeOncBuddy holds the better App Store score, 5.0 against 3.5. Both are backed by a comparable volume of ratings — 11 and 19 respectively. Written reviews point the same way: 17% of CTCAE v4.0's written reviews are positive against 100% of HemeOncBuddy's.

UpkeepUpdate frequency

CTCAE v4.0 ships an update every 44 months, HemeOncBuddy every 24 months. The most recent releases landed on November 6, 2026 and November 16, 2026 respectively.

Scorecard3 real differences · 7 level
CTCAE v4.0 versus HemeOncBuddy: the parameters behind the verdict, then further details
ParameterCTCAE v4.0HemeOncBuddy
PriceFreeFree
Rating3.5 (11 ratings)5.0 (19 ratings) — better
Positive reviews16.7% of reviews100.0% of reviews — better
Number of ratings1119 — better
Update frequencyEvery 44 monthsEvery 24 months — better
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPodiPhone, iPad, iPod — better
Requires iOS9.2 — better15.0
Further details — not scored
Size3 MB16 MB
Age rating12+17+
DeveloperThe Children's Hospital of PhiladelphiaVeli Bakalov

Customer experience

CTCAE v4.0

All ratings11 ratings
Positive45.5%
Neutral36.4%
Negative18.2%
Written reviews6 reviews
Positive16.7%
Neutral50.0%
Negative33.3%

HemeOncBuddy

All ratings17 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews2 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

CTCAE v4.0

No in-app purchases

None

HemeOncBuddy

No in-app purchases

Questions

Is CTCAE v4.0 free?
CTCAE v4.0 is free to download, with no in-app purchases.
Is HemeOncBuddy free?
HemeOncBuddy is free to download, with no in-app purchases.
Which has better reviews, CTCAE v4.0 or HemeOncBuddy?
HemeOncBuddy is rated higher. CTCAE v4.0 averages 3.5 out of 5 from 11 ratings, while HemeOncBuddy averages 5.0 from 19 ratings.
Do CTCAE v4.0 or HemeOncBuddy have ads?
Neither CTCAE v4.0 nor HemeOncBuddy shows ads.
Which is updated more often, CTCAE v4.0 or HemeOncBuddy?
CTCAE v4.0 ships an update every 44 months, and HemeOncBuddy every 24 months. Most recently, CTCAE v4.0 was updated on November 6, 2026 and HemeOncBuddy on November 16, 2026.

Other comparisons